| |
| |
|
| Insider
Information: |
Urdal David |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
669,750 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
669,750 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Director |
2014-01-03 |
644,750 |
2003-09-03 |
0 |
Premium* |
|
|
Ore Pharmaceuticals Inc |
ORXE |
Director |
2007-11-27 |
25,000 |
2007-11-27 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| DNDN |
Dendreon Corp |
Director |
– • – |
2014-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
644,750 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2013-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
619,750 |
0 |
- |
|
| DNDN |
Dendreon Corp |
Director |
– • – |
2012-06-13 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
594,750 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-10-21 |
4 |
AS |
$10.10 |
$10,262 |
D/D |
(1,016) |
579,750 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-10-17 |
4 |
AS |
$9.65 |
$19,647 |
D/D |
(2,036) |
580,766 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-10-15 |
4 |
AS |
$9.65 |
$51,270 |
D/D |
(5,313) |
582,802 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-08-09 |
4 |
OE |
$4.41 |
$57,364 |
D/D |
12,035 |
588,115 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-07-21 |
4 |
AS |
$38.75 |
$39,331 |
D/D |
(1,015) |
576,080 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-07-17 |
4 |
AS |
$38.43 |
$78,205 |
D/D |
(2,035) |
577,095 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-07-15 |
4 |
AS |
$39.19 |
$208,177 |
D/D |
(5,312) |
579,130 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-04-21 |
4 |
AS |
$41.04 |
$41,697 |
D/D |
(1,016) |
584,442 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-04-18 |
4 |
AS |
$41.68 |
$84,819 |
D/D |
(2,035) |
585,458 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-04-15 |
4 |
AS |
$41.58 |
$593,767 |
D/D |
(14,211) |
587,493 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-03-29 |
4 |
AS |
$35.00 |
$3,000,060 |
D/D |
(85,716) |
601,704 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-01-21 |
4 |
D |
$35.05 |
$37,679 |
D/D |
(1,075) |
687,420 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-01-20 |
4 |
A |
$0.00 |
$0 |
D/D |
14,026 |
688,495 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-01-18 |
4 |
D |
$36.90 |
$6,863 |
D/D |
(186) |
674,469 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-01-17 |
4 |
D |
$36.93 |
$20,053 |
D/D |
(543) |
674,655 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2011-01-15 |
4 |
D |
$36.93 |
$52,256 |
D/D |
(1,415) |
675,198 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2010-12-31 |
5 |
A |
$3.93 |
$21,249 |
D/D |
5,411 |
676,613 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2010-12-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
676,613 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2010-09-10 |
4 |
AS |
$41.61 |
$166,440 |
D/D |
(4,000) |
666,613 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2010-09-09 |
4 |
AS |
$42.55 |
$425,500 |
D/D |
(10,000) |
670,613 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2010-09-08 |
4 |
AS |
$40.37 |
$411,850 |
D/D |
(10,000) |
680,613 |
0 |
- |
|
| DNDN |
Dendreon Corp |
SVP, Chief Scientific Officer |
• – – |
2010-09-07 |
4 |
AS |
$40.41 |
$501,643 |
D/D |
(12,369) |
690,613 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
